Beijing Children's Hospital

This study tests whether the drug letermovir can prevent serious viral infections in children with EBV-related blood disorders who receive a stem cell transplant. About 80 children will be enrolled, and researchers will monitor for infections and other transplant complications. T…

This trial tests whether hetrombopag, a drug that stimulates platelet production, can help children with neuroblastoma recover their platelets faster after a stem cell transplant. Thirty children will take the drug daily for up to 6 weeks. The main goal is to see if it increases …

This study is tracking 2,600 Chinese children with growth disorders who are receiving a long-acting growth hormone injection. The goal is to see how well it works and how safe it is over the long term in real-world settings. Researchers will measure changes in height and look for…